Stock Analiz

IRulya Therapeutics Inc. (IRLA) stock forecast and price target

Price $39.80 · data as of November 13, 2026

12-month price target

Average target$76.12
Upside / downside+91.3%
Analysts8
ConsensusStrong buy
Low $65.00Average $76.12High $98.00

Gold marker: average target · white marker: today’s price ($39.80)

Analyst ratings

Strong buy 2Buy 6Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-5.00+98.5%$0
Next fiscal year
ends December 31, 2027
$-4.66+6.8%$0
Next quarter
ends December 31, 2026
$-1.13+99.2%$0
Quarter after
ends March 31, 2027
$-1.21—$0

Consensus of the analysts covering IRulya Therapeutics, updated daily.

Frequently asked questions

What is the IRulya Therapeutics stock price target?

The average 12-month target from 8 analysts is $76.12, 91.3% above the current price of $39.80 Targets range from $65.00 to $98.00.

Is IRulya Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 6 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is IRulya Therapeutics expected to earn?

Analysts expect EPS of $-5.00 for the fiscal year ending December 31, 2026 and $-4.66 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.